Paul J J. Hampel, MD

Assistant Professor of Medicine, Assistant Professor of Oncology
Department of Medicine, Mayo Clinic

N/A

Poster(s):

• 1411 - Outcomes, inequities, and access to front-line preferred therapies for chronic lymphocytic leukemia in the United States: a real-world evidence study

• 1502 - Sequencing single novel agent-based therapy for patients with CLL: A retrospective study of patients treated with covalent Bruton Tyrosine Kinase inhibitor (cBTKi) followed by B-cell lymphoma 2 inhibitor (BCL2i) versus BCL2i followed by cBTKi

• 1601 - Central Nervous System Involvement in Patients with Richter Transformation

• 1712 - Other Cancers in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma